Search Results - "MacDonald, Karen V"

Refine Results
  1. 1
  2. 2

    Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine by Marshall, Deborah A., PhD, Gonzalez, Juan Marcos, PhD, MacDonald, Karen V., MPH, Johnson, F. Reed, PhD

    Published in Value in health (2017)
    “…Abstract We examine key study design challenges of using stated-preference methods to estimate the value of whole-genome sequencing (WGS) as a specific example…”
    Get full text
    Journal Article
  3. 3

    Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation by Marshall, Deborah A, MacDonald, Karen V, Kao, Dina, Bernstein, Charles N, Kaplan, Gilaad G, Jijon, Humberto, Hazlewood, Glen, Panaccione, Remo, Nasser, Yasmin, Raman, Maitreyi, Moayyedi, Paul

    Published in Therapeutic advances in chronic disease (01-01-2024)
    “…Fecal microbiota transplantation (FMT) is a promising treatment for active ulcerative colitis (UC). Understanding patient preferences can identify treatment…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    (Un)standardized testing: the diagnostic odyssey of children with rare genetic disorders in Alberta, Canada by Michaels-Igbokwe, Christine, McInnes, Brenda, MacDonald, Karen V., Currie, Gillian R., Omar, Fadya, Shewchuk, Brittany, Bernier, Francois P., Marshall, Deborah A.

    Published in Genetics in medicine (01-02-2021)
    “…Purpose We provide a description of the diagnostic odyssey for a cohort of children seeking diagnosis of a rare genetic disorder in terms of the time from…”
    Get full text
    Journal Article
  8. 8

    Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies by Marshall, Deborah A., Gerber, Brittany, Lorenzetti, Diane L., MacDonald, Karen V., Bohach, Riley Jewel, Currie, Gillian R.

    Published in PharmacoEconomics (01-12-2023)
    “…Background and Objectives Rare diseases have a significant impact on patients, families, the health system, and society. Measuring the socioeconomic burden is…”
    Get full text
    Journal Article
  9. 9

    The value of diagnostic testing for parents of children with rare genetic diseases by Marshall, Deborah A., MacDonald, Karen V., Heidenreich, Sebastian, Hartley, Taila, Bernier, Francois P., Gillespie, Meredith K., McInnes, Brenda, Innes, A. Micheil, Armour, Christine M., Boycott, Kym M.

    Published in Genetics in medicine (01-12-2019)
    “…Purpose Exome sequencing (ES) can rapidly identify disease-causing variants responsible for rare, single-gene diseases, and potentially reduce the duration of…”
    Get full text
    Journal Article
  10. 10
  11. 11

    How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment by Marshall, Deborah A, Deal, Ken, Bombard, Yvonne, Leighl, Natasha, MacDonald, Karen V, Trudeau, Maureen

    Published in BMJ open (02-06-2016)
    “…ObjectivesGene expression profiling (GEP) of tumours informs baseline risk prediction, potentially affecting adjuvant chemotherapy decisions for women with…”
    Get full text
    Journal Article
  12. 12

    Exploring How Values of Colorectal Cancer Patients and their Caregivers Influence Treatment Decision-Making by Mirza, Raza M, Salim, Sabrin, Bell, Jennifer A H, Esplen, Mary Jane, MacDonald, Karen V, Stein, Barry D, Marshall, Deborah A

    “…As we adopt value models to inform drug reimbursement, coverage, clinical trials, and treatment choices, aligning these models to reflect patient values and…”
    Get full text
    Journal Article
  13. 13

    The influence of gene expression profiling on decisional conflict in decision making for early-stage breast cancer chemotherapy by MacDonald, Karen V, Bombard, Yvonne, Deal, Ken, Trudeau, Maureen, Leighl, Natasha, Marshall, Deborah A

    Published in European journal of cancer (1990) (01-07-2016)
    “…Abstract Background Women with early-stage breast cancer, of whom only 15% will experience a recurrence, are often conflicted or uncertain about taking…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Estimating the Burden of Osteoarthritis to Plan for the Future by Marshall, Deborah A., Vanderby, Sonia, Barnabe, Cheryl, MacDonald, Karen V., Maxwell, Colleen, Mosher, Dianne, Wasylak, Tracy, Lix, Lisa, Enns, Ed, Frank, Cy, Noseworthy, Tom

    Published in Arthritis care & research (2010) (01-10-2015)
    “…Objective With aging and obesity trends, the incidence and prevalence of osteoarthritis (OA) is expected to rise in Canada, increasing the demand for health…”
    Get full text
    Journal Article
  16. 16

    What are people willing to pay for whole-genome sequencing information, and who decides what they receive? by Marshall, Deborah A., Gonzalez, Juan Marcos, Johnson, F. Reed, MacDonald, Karen V., Pugh, Amy, Douglas, Michael P., Phillips, Kathryn A.

    Published in Genetics in medicine (01-12-2016)
    “…Whole-genome sequencing (WGS) can be used as a powerful diagnostic tool as well as for screening, but it may lead to anxiety, unnecessary testing, and…”
    Get full text
    Journal Article
  17. 17

    Symptom onset, diagnosis and management of osteoarthritis by MacDonald, Karen V, Sanmartin, Claudia, Langlois, Kellie, Marshall, Deborah A

    Published in Health reports (01-09-2014)
    “…The time between symptom onset and physician diagnosis is a period when people with osteoarthritis can make lifestyle changes to reduce pain, improve function…”
    Get full text
    Journal Article
  18. 18

    Methods for Conducting Stated Preference Research with Children and Adolescents in Health: A Scoping Review of the Application of Discrete Choice Experiments by Michaels-Igbokwe, Christine, Currie, Gillian R., Kennedy, Bryanne L., MacDonald, Karen V., Marshall, Deborah A.

    “…Background Discrete choice experiments (DCEs) are a common method used to describe and quantitatively assess preferences in health applications. Increasingly,…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Correction: Corrigendum: What are people willing to pay for whole-genome sequencing information, and who decides what they receive? by Marshall, Deborah A., Gonzalez, Juan Marcos, Johnson, F. Reed, MacDonald, Karen V., Pugh, Amy, Douglas, Michael P., Phillips, Kathryn A.

    Published in Genetics in medicine (01-01-2018)
    “…Correction to: Genetics in Medicine (2016) 18, 1295–1302 doi:10.1038/gim.2016.61 In the published version of this article, the ranges of willingness to pay on…”
    Get full text
    Journal Article